Sentences with phrase «growth in a time of austerity»

Confusingly, in a motion entitled Generating Jobs and Growth in a time of Austerity — due to be debated on Monday (24th September) at the party's Brighton Conference — the Lib Dems appear to want to do both.

Not exact matches

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

The second problem is that in order to get some of its debt absolved, Puerto Rico agreed to impose the harsh austerity measures — reducing education and health spending, for instance — that hurt growth at the same time that thousands are fleeing to the mainland in search of economic opportunity.

«This issue has now gone beyond Stephen Hester, this is about a prime minister who promised to rein in excess and says to the country in a time of austerity, when his economic policies have choked off growth, that we are all in it together - how hollow is his rhetoric in light of what we have just seen today.

And Alexander today in a policy motion speech to conference certainly did his damnedest to defend the coalition, opposing an amendment to his «Generating Growth and Jobs in a Time of Austerity» motion to abandon the coalition's fiscal mandate.

Short - term actions in a time of budget crisis and financial austerity might become the triggers of long - term underinvestment in the ultimate fuel of economic growth, basic research in science.

Following the years of war - time austerity and slow post-war recovery, it was not until the 1950's that the growth in London's art galleries and auction houses began to rival those of Paris and shift the focus of the European market for modern art to the British capital.